Browse result page of THPdb

The total number entries retrieved from this search are 80

ID	ThPPID	Name	Peptide Sequence	Length	Functional Classification	Disease	Brand	Company	Physical Appearance	Route of Administartion	Category	Target
ID1028	ThPPIDTh1005	NameEtanercept	Peptide SequenceLPAQVAFTPYAPEPGSTCRL Full view	Length255	Functional ClassificationIIa	DiseaseImmunological	BrandEnbrel	CompanyImmunex Corp	Physical AppearanceLyophilized powder.	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetTumor necrosis factor,Tumor necrosis factor receptor superfamily member 1B,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c,Lymphotoxin-alpha,Low affinity immunoglobulin gamma Fc region re
ID1029	ThPPIDTh1005	NameEtanercept	Peptide SequenceLPAQVAFTPYAPEPGSTCRL Full view	Length255	Functional ClassificationIIa	DiseaseImmunological	BrandEnbrel Sureclick	CompanyN.A.	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetTumor necrosis factor,Tumor necrosis factor receptor superfamily member 1B,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c,Lymphotoxin-alpha,Low affinity immunoglobulin gamma Fc region re
ID1049	ThPPIDTh1008	NamePeginterferon alfa-2a	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological	BrandPegasys	CompanyHoffman-La Roche Inc	Physical AppearanceSterile, preservative-free, colorless to light yellow injectable solution	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1059	ThPPIDTh1010	NameInterferon alfa-n1	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseInfectious /Immunological	BrandWellferon	CompanyGlaxoSmithKline	Physical AppearanceSolution	Route of AdministartionInjection	CategoryAntiviral Agents, Immunologic factors, Immunosuppressiv agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1110	ThPPIDTh1015	NameInterferon alfa-n3	Peptide SequenceAlpha-2A:CDLPQTHSLG< Full view	Length235	Functional ClassificationIb	DiseaseImmunological	BrandAlferon	CompanyInterferon Sciences Inc.	Physical AppearanceSolution	Route of AdministartionInjection	CategoryImmunosuppressive Agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1111	ThPPIDTh1015	NameInterferon alfa-n3	Peptide SequenceAlpha-2A:CDLPQTHSLG< Full view	Length235	Functional ClassificationIb	DiseaseImmunological	BrandAlferon LDO	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryImmunosuppressive Agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1112	ThPPIDTh1015	NameInterferon alfa-n3	Peptide SequenceAlpha-2A:CDLPQTHSLG< Full view	Length235	Functional ClassificationIb	DiseaseImmunological	BrandAlferon N Injection	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryImmunosuppressive Agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1117	ThPPIDTh1016	NamePegfilgrastim	Peptide SequenceMTPLGPASSLPQSFLLKCLE Full view	Length175	Functional ClassificationIb	DiseaseImmunological	BrandNeulasta	CompanyAmgen Inc.	Physical AppearanceSolution	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents, Anti-neutropenic agents	TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase
ID1120	ThPPIDTh1017	NameSargramostim	Peptide SequenceAPARSPSPSTQPWEHVNAIQ Full view	Length127	Functional ClassificationIb	DiseaseImmunological	BrandLeucomax	CompanyNovartis	Physical AppearanceSolution	Route of AdministartionSubcutaneous and Intravenous infusion	CategoryImmunosuppressive Agents	TargetGranulocyte-macrophage colony-stimulating factor receptor subunit alpha,Interleukin-3 receptor subunit alpha,Cytokine receptor common subunit beta,Syndecan-2,Bone marrow proteoglycan
ID1121	ThPPIDTh1017	NameSargramostim	Peptide SequenceAPARSPSPSTQPWEHVNAIQ Full view	Length127	Functional ClassificationIb	DiseaseImmunological	BrandLeukine	CompanyBerlex Laboratories Inc	Physical AppearanceSterile, preserved (1.1% benzyl alcohol), injectable solution (500 mcg/mL) and also as sterile, white, preservative free lyophilized powder (250 mcg) that requires reconstitution with 1 mL sterile water for Injection	Route of AdministartionSubcutaneous Injection (SC) or Intravenous infusion (IV)	CategoryImmunosuppressive Agents	TargetGranulocyte-macrophage colony-stimulating factor receptor subunit alpha,Interleukin-3 receptor subunit alpha,Cytokine receptor common subunit beta,Syndecan-2,Bone marrow proteoglycan
ID1135	ThPPIDTh1019	NamePeginterferon alfa-2b	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological	BrandPEG-Intron	CompanySchering Corp	Physical AppearancePowder	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1136	ThPPIDTh1019	NamePeginterferon alfa-2b	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological	BrandUnitron PEG	CompanyN.A.	Physical AppearanceLyophilized powder	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1180	ThPPIDTh1023	NameAnakinra	Peptide SequenceMRPSGRKSSKMQAFRIWDVN Full view	Length153	Functional ClassificationIIa	DiseaseImmunological	BrandKineret	CompanyAmgen Inc	Physical AppearanceSterile, clear, colorless-to-white, preservative free solution	Route of AdministartionSubcutaneous (SC) administration	CategoryImmunosuppressive Agents, Anti-rheumatic agents	TargetInterleukin-1 receptor type 1
ID1193	ThPPIDTh1025	NameIntravenous Immunoglobulin	Peptide SequenceIGG1:PSALTQPPSASGSLG Full view	Length250	Functional ClassificationIa	DiseaseImmunological	BrandCivacir	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryImmunosuppressive Agents, Immunologic factors, Anti-infective agents	TargetHigh affinity immunoglobulin gamma Fc receptor I,High affinity immunoglobulin gamma Fc receptor IB,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc reg
ID1194	ThPPIDTh1025	NameIntravenous Immunoglobulin	Peptide SequenceIGG1:PSALTQPPSASGSLG Full view	Length250	Functional ClassificationIa	DiseaseImmunological	BrandFlebogamma	CompanyInstituto Grifols SA	Physical AppearanceSterile, clear or slightly opalescent and colorless to pale yellow, liquid	Route of AdministartionIntravenous infusion	CategoryImmunosuppressive Agents, Immunologic factors, Anti-infective agents	TargetHigh affinity immunoglobulin gamma Fc receptor I,High affinity immunoglobulin gamma Fc receptor IB,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc reg
ID1195	ThPPIDTh1025	NameIntravenous Immunoglobulin	Peptide SequenceIGG1:PSALTQPPSASGSLG Full view	Length250	Functional ClassificationIa	DiseaseImmunological	BrandGamunex	CompanyTalecris Biotherapeutics	Physical AppearanceSterile solution	Route of AdministartionIntravenous infusion	CategoryImmunosuppressive Agents, Immunologic factors, Anti-infective agents	TargetHigh affinity immunoglobulin gamma Fc receptor I,High affinity immunoglobulin gamma Fc receptor IB,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc reg
ID1226	ThPPIDTh1030	NameInterferon gamma-1b	Peptide SequenceCYCQDPYVKEAENLKKYFNA Full view	Length146	Functional ClassificationIb	DiseaseImmunological	BrandActimmune	CompanyInterMune Inc	Physical AppearanceSterile, clear, colorless solution	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents	TargetInterferon gamma receptor 1,Interferon gamma receptor 2
ID1229	ThPPIDTh1031	NameInterferon Alfa-2a, Recombinant	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological	BrandRoferon A	CompanyHoffmann-La Roche Inc	Physical AppearanceSolution	Route of AdministartionSubcutaneous Injection	CategoryN.A.	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1230	ThPPIDTh1031	NameInterferon Alfa-2a, Recombinant	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological	BrandVeldona	CompanyAmarillo Biosciences	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryN.A.	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1265	ThPPIDTh1038	NameOmalizumab	Peptide SequenceHeavy chain:EVQLVESG Full view	Length243	Functional ClassificationIIa	DiseaseImmunological	BrandXolair	CompanyGenentech Inc	Physical AppearanceSterile, white, preservative free, lyophilized powde	Route of AdministartionSubcutaneous Injection	CategoryAnti-Allergic Agents, Anti-asthmatic, Immuno-suppressive agents	TargetHigh affinity immunoglobulin epsilon receptor subunit alpha and beta
ID1316	ThPPIDTh1044	NameAdalimumab	Peptide SequenceLight-chain:DIQMTQS< Full view	Length230	Functional ClassificationIc	DiseaseImmunological	BrandHumira	CompanyAbbott Laboratories	Physical AppearanceSterile, preservative-free solution	Route of AdministartionSubcutaneous administration	CategoryImmunosuppressive Agents, Anti-inflammatory, Antirheumatic agents	TargetTumor necrosis factor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamm
ID1341	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandAvonex	CompanyBiogen Inc	Physical AppearanceLyophilized powder vial, Sterile liquid as single used prefilled syringe and also available as single use prefilled autoinjector.	Route of AdministartionIntramuscular Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1342	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandBetaferon	CompanyBayer	Physical AppearancePowder and solvent that are made upto make solution.	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1343	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandBetaseron	CompanyMerck	Physical AppearanceSterile, white to off-white powder	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1344	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandBlastoferon	CompanySidus	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1345	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandExtavia	CompanyNovartis	Physical AppearanceSterile, white to off-white powder	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1346	ThPPIDTh1049	NameInterferon beta-1a	Peptide SequenceMSYNLLGFLQRSSNFQCQKL Full view	Length166	Functional ClassificationIb	DiseaseCancer/Infectious/Immunological	BrandRebif	CompanyMerck	Physical AppearanceSterile solution in a prefilled syringe or REBIF Rebidose autoinjector	Route of AdministartionSubcutaneous Injection	CategoryImmunosuppressive Agents, Antineoplastic, Antiviral, Immunologic factors	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1368	ThPPIDTh1054	NameInfliximab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological	BrandREMICADE	CompanyCentocor Inc	Physical AppearanceSterile, white, lyophilized powder, following reconstitution with 10 mL of Sterile Water for Injection, USP, the resulting pH is approximately 7.2.	Route of AdministartionIntravenous infusion	CategoryAntirheumatic Agents, Anti-Inflammatory Agents, Non-Steroidal, Dermatologic Agents, Gastrointestinal Agents and Immunosuppressive Agents	TargetTumor necrosis factor
ID1376	ThPPIDTh1057	NameInterferon beta-1b	Peptide SequenceMSYNLLGFLQRSSNFQSQKL Full view	Length166	Functional ClassificationIb	DiseaseImmunological	BrandBetaseron	CompanyBayer	Physical AppearanceSterile, white to off-white powder	Route of AdministartionSubcutaneous Injection	CategoryAdjuvants, Immunologic and Immunosuppressive Agents	TargetN.A.
ID1377	ThPPIDTh1057	NameInterferon beta-1b	Peptide SequenceMSYNLLGFLQRSSNFQSQKL Full view	Length166	Functional ClassificationIb	DiseaseImmunological	BrandBetaferon	CompanyBayer	Physical AppearancePowder and solvent that are made upto make solution.	Route of AdministartionSubcutaneous Injection	CategoryAdjuvants, Immunologic and Immunosuppressive Agents	TargetN.A.
ID1378	ThPPIDTh1057	NameInterferon beta-1b	Peptide SequenceMSYNLLGFLQRSSNFQSQKL Full view	Length166	Functional ClassificationIb	DiseaseImmunological	BrandExtavia	CompanyNovartis	Physical AppearanceSterile, white to off-white powder	Route of AdministartionSubcutaneous Injection	CategoryAdjuvants, Immunologic and Immunosuppressive Agents	TargetN.A.
ID1379	ThPPIDTh1058	NameInterferon alfacon-1	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological/Infectious	BrandINFERGEN	CompanyKadmon Pharmaceuticals, LLC.	Physical AppearanceSterile, clear, colorless, preservative-free liquid	Route of AdministartionSubcutaneous Injection	CategoryAntiviral Agents and Immunosuppressive Agents	TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1389	ThPPIDTh1062	NameRituximab	Peptide SequenceHeavy Chain: QVQLQQP Full view	Length664	Functional ClassificationIIa	DiseaseCancer/Immunological	BrandRituxan	CompanyBiogen Idec Inc., and Genentech USA, Inc	Physical AppearanceSterile, clear, colorless, preservative-free liquid concentrate	Route of Administartion Intravenous administration	CategoryAntineoplastic Agents, Immunologic Factors and Antirheumatic Agents	TargetB-lymphocyte antigen CD20,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c, Receptor tyrosine-protein kinase erbB-2,Epidermal growth factor receptor,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor I
ID1398	ThPPIDTh1063	NameBasiliximab	Peptide SequenceHeavy Chain: QLQQSGT Full view	Length657	Functional ClassificationIIa	DiseaseImmunological	BrandSimulect	CompanyNovartis	Physical AppearanceSterile lyophilisate which is available in 6 mL colorless glass vials and is available in 10 mg and 20 mg strength	Route of Administartionintravenous infusion mainly or bolus (if no allergic reactions occurs)	CategoryImmunosuppressive Agents	TargetN.A.
ID1400	ThPPIDTh1064	NameMuromonab	Peptide SequenceHeavy Chain: QVQLQQS Full view	Length664	Functional ClassificationIIa	DiseaseImmunological	BrandORTHOCLONE OKT3 STERILE SOLUTION	CompanyCentocor Ortho Biotech, L.P.	Physical AppearanceSterile Solution is a murine monoclonal antibody to the CD3 antigen of human T cells which functions as an immunosuppressant.	Route of AdministartionFor Intravenous Use Only	CategoryImmunologic Factors and Immunosuppressive Agents	TargetN.A.
ID1442	ThPPIDTh1078	NameEfalizumab	Peptide SequenceLight Chain:DIQMTQSP Full view	Length229	Functional ClassificationIIa	DiseaseImmunological	BrandRAPTIVA	CompanyGenentech, Inc.	Physical AppearanceSterile, white to off-white, lyophilized powder in single-use glass vials	Route of AdministartionSubcutaneous injection.ÂÂÂ	CategoryImmunosuppressive Agents	TargetIduronic acid
ID1449	ThPPIDTh1081	NameAntithymocyte Globulin	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological	BrandAntithymocyte globulin	CompanyPfizer	Physical AppearanceN.A.	Route of AdministartionIntravenous infusion	CategoryImmunologic Factors and Immunosuppressive Agents	TargetN.A.
ID1451	ThPPIDTh1082	NameFilgrastim	Peptide SequenceMTPLGPASSLPQSFLLKCLE Full view	Length175	Functional ClassificationIb	DiseaseImmunological	BrandN.A.	CompanyN.A.	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryImmunosuppressive Agents, Antineutropenic Agents and Hematopoietic Agents	TargetLutropin-choriogonadotropic hormone receptor,Follicle-stimulating hormone receptor
ID1456	ThPPIDTh1086	NameInterferon Alfa-2B, Recombinant	Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full view	Length165	Functional ClassificationIb	DiseaseImmunological	BrandINTRON® A	CompanyMerck	Physical AppearancePowder or solution	Route of AdministartionIntramuscular, Subcutaneous, Intralesional, or Intravenous injection	CategoryImmunosuppressive Agents	TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase, Coagulation factor X,Coagulation factor XI,Coagulation factor VII,Coagulation factor VIII,Prothrombin,Prolow-density lipoprotein receptor-related protein 1,Vitamin K-dependent gamma-carboxylase, Platelet-derived growth factor receptor beta,Platelet-derived growth factor receptor alpha,Alpha-2-macroglobulin
ID1466	ThPPIDTh1090	NameDaclizumab	Peptide SequenceQVQLVQSGAEVKKPGSSVKV Full view	Length674	Functional ClassificationIIa	DiseaseImmunologicals	BrandZenapax	CompanyRoche	Physical AppearanceClear, sterile, colorless concentrate for further dilution and intravenous administration	Route of AdministartionIntravenous injection	CategoryImmunosuppressive Agents	TargetFusion glycoprotein F0,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1495	ThPPIDTh1102	NameAbatacept	Peptide SequenceMHVAQPAVVLASSRGIASFV Full view	Length357	Functional ClassificationIIa	DiseaseImmunological	BrandORENCIA	CompanyBristol-Myers Squibb	Physical AppearanceLyophilized powder, supplied as a sterile, white, preservative-free, lyophilized powder for intravenous administration	Route of AdministartionIntravenous infusion and Subcutaneous injection	CategoryAntirheumatic Agents and Immunosuppressive Agents	TargetT-lymphocyte activation antigen CD80,T-lymphocyte activation antigen CD86
ID1531	ThPPIDTh1110	NameThymalfasin	Peptide SequenceSDAAVDTSSEITTKDLKEKK Full view	Length28	Functional ClassificationIb	DiseaseInfectious/Immunological	BrandZadaxin	CompanySciClone Pharmaceuticals (SCLN)	Physical AppearanceN.A.	Route of AdministartionSubcutaneous injection	CategoryN.A.	TargetN.A.
ID1532	ThPPIDTh1111	NameDefibrotide	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIb	DiseaseImmunological	BrandNoravid	Companysanofi-aventis	Physical AppearanceN.A.	Route of AdministartionN.A.	CategoryAntithrombins	TargetAdenosine receptor A1,Adenosine receptor A2a,Adenosine receptor A2b
ID1537	ThPPIDTh1116	NameCanakinumab	Peptide SequenceH-GAMMA-1 (VH(1-118) Full view	Length842	Functional ClassificationIIIb	DiseaseImmunological	BrandILARISÂÂÂ	CompanyNovartis Pharmaceuticals	Physical AppearanceWhite, preservative-free, lyophilized powder	Route of AdministartionSubcutaneous injection	CategoryAnti-Inflammatory Agents and Monoclonal antibodies	TargetInterleukin-1 beta
ID1550	ThPPIDTh1119	NameTocilizumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological	BrandACTEMRA	CompanyGenentech	Physical AppearanceSterile, preservative-free solution, colorless to pale yellow liquid, with a pH of about 6.5	Route of AdministartionIntravenous infusion, Subcutaneous injection	CategoryN.A.	TargetInterleukin-6 receptor subunit alpha
ID1562	ThPPIDTh1122	NameRilonacept	Peptide Sequencerilonacept|Homo sapi Full view	Length880	Functional ClassificationIIa	DiseaseImmunological	BrandArcalyst	CompanyRegeneron Pharmaceuticals	Physical AppearanceSterile, white to off-white, lyophilized powder	Route of AdministartionSubcutaneous injection	CategoryImmunosuppressive Agents	TargetInterleukin-1 beta,Interleukin-1 alpha,Interleukin-1 receptor antagonist protein
ID1583	ThPPIDTh1125	NameGolimumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIb	DiseaseImmunological	BrandSimponi Injection	CompanyN.A.	Physical AppearanceClear to slightly opalescent, colorless to light yellow solution	Route of AdministartionSubcutaneous injection	CategoryAntipsoriatic Agents and Monoclonal antibodies and TNF inhibitor	TargetTumor necrosis factor
ID1584	ThPPIDTh1125	NameGolimumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIb	DiseaseImmunological	BrandSimponi Injection	CompanyN.A.	Physical AppearanceSterile concentrated solution of the golimumab antibody	Route of AdministartionIntravenous infusion	CategoryAntipsoriatic Agents and Monoclonal antibodies and TNF inhibitor	TargetTumor necrosis factor
ID1596	ThPPIDTh1126	NameBelatacept	Peptide SequenceMHVAQPAVVLASSRGIASFV Full view	Length357	Functional ClassificationIIa	DiseaseImmunological	BrandNulojix	CompanyBristol-Myers Squibb	Physical AppearanceSterile, white or off-white lyophilized powder	Route of AdministartionIntravenous injection	CategoryAntirheumatic Agents and Immunosuppressive Agents	TargetT-lymphocyte activation antigen CD86,T-lymphocyte activation antigen CD80
ID1609	ThPPIDTh1132	NameBelimumab	Peptide SequenceN.A. Full view	Length0	Functional ClassificationIIa	DiseaseImmunological	BrandBenlysta	CompanyGlaxoSmithKline	Physical AppearanceSterile, white to off-white, preservative-free, lyophilized powder	Route of AdministartionIntravenous infusion	CategoryMonoclonal antibodies	TargetTumor necrosis factor ligand superfamily member 13B